Therapeutic Boon or Hidden Bane? Semaglutide for Weight Loss in Non-diabetics
Semaglutide, a long-acting GLP-1 receptor agonist indicated for type 2 diabetes, has recently been approved by the US FDA for chronic weight management in non-diabetic obese patients. It works on GLP-1 receptors in the gut, pancreas, and hypothalamus to stimulate insulin release, decelerate stomach emptying, and augmen...